𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ENHANCEMENT OF AMYLOIDOSIS BY HIGH-DOSE PREDNISOLONE THERAPY IN MULTIPLE MYELOMA

✍ Scribed by Tadashi Kanoh; Yasuyuki Nakamura; Chuichi Kawai

Book ID
114791178
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
92 KB
Volume
43
Category
Article
ISSN
0902-4441

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pulsed high dose oral prednisolone in re
Pulsed high dose oral prednisolone in relapsed or refractory multiple myeloma
✍ Dr. D. R. Norfolk; J. A. Child πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 392 KB

Seventeen unselected patients with relapsed or refractory multiple myeloma were treated with oral prednisolone 60 mg per m2 for five consecutive days with nine-day treatment-free intervals. Of the fourteen patients who completed at least six courses of treatment there were five good responses (Chron

Recombinant interferon-ALPHA2b and high
Recombinant interferon-ALPHA2b and high dose methyl prednisolone in relapsed and resistant multiple myeloma
✍ R. K. Ganjoo; P. W. M. Johnson; M. L. Evans; A Williams; A. Z. S. Rohatiner; T. πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 483 KB

## Abstract Twenty‐one patients with referactory myeloma (10 primary resistant and 11 relapsed resistant) were treated with a combination of high dose methyl prednisolone and recombinant interferon alpha2b (IFN‐α2b). This treatment included three megaunits/m^2^ of IFN‐α2b three times a week for 12